M
Mexico Centre For Clinical Research | Neurology Department
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
Ocrelizumab
Fenebrutinib
Gantenerumab
Interferon
Teriflunomide
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
3 of 6 total trials
This is a Phase IIIb, single-arm, multicenter, OLE study. Participants receiving ocrelizumab as an investigational medicinal product (IMP) in a Roche...
Active, not recruiting
Multiple Sclerosis
Drug: Ocrelizumab
A study to evaluate the efficacy and safety of fenebrutinib on disability progression in adult participants with Primary Progressive Multiple Scleros...
Active, not recruiting
Multiple Sclerosis, Primary Progressive
Drug: Placebo matched to ocrelizumab
Drug: Fenebrutinib
A study to evaluate the efficacy and safety of fenebrutinib on disability progression and relapse rate in adult participants with RMS. Eligible parti...
Active, not recruiting
Relapsing Multiple Sclerosis
Drug: Teriflunomide
Drug: Fenebrutinib
Trial sponsors
Clinical trials
Research sites
Resources
Legal
© Copyright 2024 Veeva Systems